Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Clinics in Liver Disease|October 3, 2024
Alcohol and Hepatocellular CarcinomaNghiem B Ha, Francis YaoLiver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 2026
Pre-transplant lipase elevation: A single-center study of clinically significant pancreatitis in liver transplant candidatesPeyton Crest, Liang Ge, Francis Yao, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 25, 2025
Optimizing liver transplant candidacy in patients with cirrhosis and obesityNghiem B Ha, Julie K Heimbach, Bilal HameedJournal of Clinical Gastroenterology|May 29, 2015
Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical PracticeNghiem B Ha, Huy N Trinh, Lisa Rosenblatt, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2023
Real-World Experience With Tofacitinib Dose De-Escalation in Patients With Moderate and Severe Ulcerative ColitisAmy Yu, Nghiem B Ha, Bingyan Shi, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 3, 2023
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosisNghiem B Ha, Bo Fan, Amy M Shui, et al.Journal of Clinical Gastroenterology|April 10, 2015
Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy: A Matched Case-Cohort StudyNghi B Ha, Kevin Ku, Nghiem B Ha, et al.Journal of Clinical Gastroenterology|December 10, 2015
Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir MonotherapyKevin T Chaung, Connor O'Brien, Nghiem B Ha, et al.Journal of Clinical Gastroenterology|October 24, 2012
Response to higher dose of entecavir 1.0 mg daily in patients with partial response to entecavir 0.5 mg dailyNghiem B Ha, Nghi B Ha, Huy N Trinh, et al.Clinics in Liver Disease|November 28, 2024
Real-World Management of Hepatocellular Carcinoma: Selected Case Presentations Highlighting the Dilemmas of SurveillanceElizabeth Zheng, Francis YaoPageof 7